KEGG pathway enrichment analysis results showed that the top ten signaling pathways of CRCJ for SS treatment are as follows: human cytomegalovirus infection, toll-like receptor signaling pathway, pertussis, allograft rejection, Th17 cell differentiation, p53 signaling pathway, chronic myeloid leukemia, glioma, graft vs host disease, and the Ras signaling pathway. This evidence concerns the gene TP53 and synovial sarcoma.